96 related articles for article (PubMed ID: 17702776)
1. Neurological picture. FDG-PET in meningeal lymphomatosis.
Shinohara M; Kosaka S; Okamura T; Yamamoto T
J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):974. PubMed ID: 17702776
[No Abstract] [Full Text] [Related]
2. Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.
Mukherjee A; Agarwal KK; Gogia A; Bal C; Kumar R
Clin Nucl Med; 2016 Apr; 41(4):e206-7. PubMed ID: 26914553
[TBL] [Abstract][Full Text] [Related]
3. Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography.
Sam JW; Levine MS; Farner MC; Schuster SJ; Alavi A
Clin Nucl Med; 2002 May; 27(5):330-3. PubMed ID: 11953565
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project.
Bailly C; Carlier T; Berriolo-Riedinger A; Casasnovas O; Gyan E; Meignan M; Moreau A; Burroni B; Djaileb L; Gressin R; Devillers A; Lamy T; Thieblemont C; Hermine O; Kraeber-Bodéré F; Le Gouill S; Bodet-Milin C
Haematologica; 2020 Jan; 105(1):e33-e36. PubMed ID: 31371411
[No Abstract] [Full Text] [Related]
5. [18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.
Gill S; Wolf M; Prince HM; Januszewicz H; Ritchie D; Hicks RJ; Seymour JF
Clin Lymphoma Myeloma; 2008 Jun; 8(3):159-65. PubMed ID: 18650179
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT in a case of bilateral lacrimal gland infiltration by mantle cell lymphoma.
Martínez-Esteve A; García-Gómez FJ; Borrero-Martin JJ; Fajardo-Pico E; Borrego-Dorado I
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):396-7. PubMed ID: 25956958
[No Abstract] [Full Text] [Related]
7. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Lamonica D; Graf DA; Munteanu MC; Czuczman MS
J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
[TBL] [Abstract][Full Text] [Related]
8. "Hood Sign" in Nuclear Medicine: An Unusual Presentation of Mantle Cell Lymphoma as Detected on FDG PET/CT.
Prakash A; Purandare N; Shah S; Agrawal A; Puranik A; Rangarajan V
Clin Nucl Med; 2022 Dec; 47(12):e731-e732. PubMed ID: 35961639
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUV
Russler-Germain DA; Calhoun BR; Wu N; Watkins MP; Siegel BA; Bartlett NL; Mhlanga JC
Leuk Lymphoma; 2023; 64(11):1870-1874. PubMed ID: 37489928
[No Abstract] [Full Text] [Related]
10. Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma.
Alavi A; Shrikanthan S; Aydin A; Talanow R; Schuster S
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):261-6. PubMed ID: 21658653
[TBL] [Abstract][Full Text] [Related]
11. Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
Hofman MS; Fields P; Yung L; Mikhaeel NG; Ireland R; Nunan T
Br J Haematol; 2007 Jun; 137(5):386. PubMed ID: 17355259
[No Abstract] [Full Text] [Related]
12. F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome.
Bilici A; Ustaalioglu BB; Seker M; Canpolat N; Gumus M
Clin Nucl Med; 2010 Mar; 35(3):211-2. PubMed ID: 20173464
[No Abstract] [Full Text] [Related]
13. What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?
Gill S; Hicks RJ; Seymour JF
Leuk Lymphoma; 2008 Sep; 49(9):1653-6. PubMed ID: 18798097
[No Abstract] [Full Text] [Related]
14. The aggressiveness and extent of meningioma imaged by combined fluorine-18 FDG and positron emission tomography.
Wong CO; Bleza MV; Dworkin HJ
Clin Nucl Med; 2000 Sep; 25(9):736. PubMed ID: 10983771
[No Abstract] [Full Text] [Related]
15. F-18 fluorodeoxyglucose positron emission tomography in a transitional meningioma.
Amemiya S; Aoki S; Akahane M; Ohtomo K
Clin Nucl Med; 2009 Jul; 34(7):462-3. PubMed ID: 19542958
[No Abstract] [Full Text] [Related]
16. Prognostic value of
Laffon E; Marthan R
Haematologica; 2020 Jan; 105(1):e41. PubMed ID: 31894098
[No Abstract] [Full Text] [Related]
17. 18F-FDG PET/CT in Intramuscular Mantle Cell Lymphoma With Elongated Lymphomatous Neurovascular Extension.
Hod N; Levin D; Anconina R; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2019 Apr; 44(4):e298-e300. PubMed ID: 30688737
[TBL] [Abstract][Full Text] [Related]
18. A case of primary leptomeningeal melanoma evaluated on FDG PET/CT.
Golden MJ; Wheir WH; Katzman J; Turk ZA; Hartshorne MF
Clin Nucl Med; 2011 Oct; 36(10):919-21. PubMed ID: 21892047
[No Abstract] [Full Text] [Related]
19. Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Tateishi U; Tatsumi M; Terauchi T; Ishizawa K; Ogura M; Tobinai K
Cancer Sci; 2011 Feb; 102(2):414-8. PubMed ID: 21156007
[TBL] [Abstract][Full Text] [Related]
20. Parapharyngeal meningioma extending from the intracranial space evaluated by FDG PET.
Kado H; Ogawa T; Okudera T; Kanno I; Hatazawa J; Uemura K
J Nucl Med; 1998 Feb; 39(2):302-4. PubMed ID: 9476940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
